ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Transdermal HRT for Women: Best Bet for Lower VTE Risk
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 134418" data-attributes="member: 3"><p>When a blood clot breaks loose and travels in the blood, this is called a venous thromboembolism (VTE). The abbreviation DVT/PE refers to a VTE where a deep vein thrombosis (DVT) has moved to the lungs (PE or pulmonary embolism).</p><p></p><p>"Among different types of hormone replacement therapy (HRT), a transdermal formulation appeared safest in terms of venous thromboembolism (VTE) risk, according to researchers in England.</p><p></p><p>In a retrospective analysis of about 80,000 women who experienced VTE and some 390,000 non-VTE control women, 7.2% of VTE patients were exposed to HRT within 90 days of the index date compared with 5.5% controls, according to Yana Vinogradova, PhD, of the University of Nottingham, and colleagues.</p><p></p><p></p><p></p><p>But there was no added risk for VTE associated with HRT patches, gel, or subcutaneous formulas (adjusted odds ratio 0.93, 95% CI 0.87-1.01), they wrote in <a href="http://dx.doi.org/10.1136/bmj.k4810" target="_blank"><em>BMJ</em></a>."</p><p></p><p><a href="https://www.medpagetoday.com/obgyn/hrt/77345" target="_blank">Source</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 134418, member: 3"] When a blood clot breaks loose and travels in the blood, this is called a venous thromboembolism (VTE). The abbreviation DVT/PE refers to a VTE where a deep vein thrombosis (DVT) has moved to the lungs (PE or pulmonary embolism). "Among different types of hormone replacement therapy (HRT), a transdermal formulation appeared safest in terms of venous thromboembolism (VTE) risk, according to researchers in England. In a retrospective analysis of about 80,000 women who experienced VTE and some 390,000 non-VTE control women, 7.2% of VTE patients were exposed to HRT within 90 days of the index date compared with 5.5% controls, according to Yana Vinogradova, PhD, of the University of Nottingham, and colleagues. But there was no added risk for VTE associated with HRT patches, gel, or subcutaneous formulas (adjusted odds ratio 0.93, 95% CI 0.87-1.01), they wrote in [URL='http://dx.doi.org/10.1136/bmj.k4810'][I]BMJ[/I][/URL]." [URL='https://www.medpagetoday.com/obgyn/hrt/77345']Source[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Transdermal HRT for Women: Best Bet for Lower VTE Risk
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top